RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Shyamali Mukherjee to India

This is a "connection" page, showing publications Shyamali Mukherjee has written about India.
Connection Strength

0.431
  1. Rana A, Bhattacharya P, Ganguly S, Saha S, Naskar S, Ghosh S, Shaikh AR, Koley M, Saha S, Mukherjee SK. Individualized Homeopathic Medicinal Products in the Treatment of Post-COVID-19 Conditions: A Double-Blind, Randomized, Placebo-Controlled, Feasibility Trial. J Integr Complement Med. 2025 Jan; 31(1):64-74.
    View in: PubMed
    Score: 0.219
  2. Banerjee A, Ganguly S, Saha S, Bhattacharyya P, Naskar S, Mukherjee D, Ghosh S, Maji P, Saha S, Shaikh AR, Ghosh P, Chatterjee C, Koley M, Mukherjee SK. Individualized homeopathic medicines in preventing the progression from pre-diabetes to diabetes: A double-blind, randomized, placebo-controlled, parallel-arm trial. Explore (NY). 2024 Sep-Oct; 20(5):102995.
    View in: PubMed
    Score: 0.212
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support